Library

Home > Library

Search results : regulation

Bidenomics 2.0: trade, taxation, and technology

2024-02-14This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 4 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Bidenomics

2022-09-21This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 3 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Bank leverage and capital bias adjustment through the macroeconomic cycle

2020-12-31This simulation study delves into the quantitative effects of the recent proposal for more robust bank capital adequacy.

This simulation study delves into the quantitative effects of the recent proposal for more robust bank capital adequacy.+See More
Key motifs in the merry medley of Trump economic reform 2016-2020

2020-06-06This ebook delves into key financial topics and stock investment memes blog posts and essays.

This ebook offers the key motifs in the merry medley of Trump economic reform 2016-2020: (1) Federal Reserve monetary policy decisions and interest rate adjustments in response to inflationary fluctuations, economic output g...+See More
Algorithmic credit portfolio segmentation

2013-06-06This research article proposes a new algorithmic model for credit portfolio segmentation.

This research article proposes a new algorithmic model for credit portfolio segmentation.+See More
1

Blog+More

CNBC news anchor Becky Quick interviews Warren Buffett in early-2019.

James Campbell

2019-04-07 13:39:00 Sunday ET

CNBC news anchor Becky Quick interviews Warren Buffett in early-2019.

CNBC news anchor Becky Quick interviews Warren Buffett in early-2019. Buffett explains the fact that book value fluctuations are a metric that has lost rele

+See More

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

Monica McNeil

2025-10-31 12:26:00 Friday ET

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi

+See More

Warren Buffett places his $58 billion stock bets on Apple, American Express, and Goldman Sachs.

Rose Prince

2019-04-05 08:25:00 Friday ET

Warren Buffett places his $58 billion stock bets on Apple, American Express, and Goldman Sachs.

Warren Buffett places his $58 billion stock bets on Apple, American Express, and Goldman Sachs. Berkshire Hathaway owns $18 billion equity stakes in America

+See More

Eric Posner and Glen Weyl propose radical reforms to resolve key market design problems for better democracy and globalization.

Chanel Holden

2023-02-14 09:31:00 Tuesday ET

Eric Posner and Glen Weyl propose radical reforms to resolve key market design problems for better democracy and globalization.

Eric Posner and Glen Weyl propose radical reforms to resolve key market design problems for better democracy and globalization. Eric Posner and Glen Weyl

+See More

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023.

Daisy Harvey

2023-02-03 08:27:00 Friday ET

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023.

Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023. Our proprietary alpha investment model outperforms the ma

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More